Plain-English translation of NCT06150326 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a pilot study testing whether Activon® (medical honey) can help wounds heal faster in patients staying in the intensive care unit. Researchers will compare honey treatment to standard wound care recommended by French health authorities. The goal is to understand if this treatment works better for critically ill patients with acute wounds.
Medical honey has shown promise in treating chronic and acute wounds in other patient populations, but it has never been studied in critically ill intensive care patients. This trial will help doctors understand whether this treatment could improve wound healing and reduce pain in this specific group of vulnerable patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, your wound (or wounds, up to three) will be randomly assigned to receive either medical honey treatment or standard care. Researchers will take photographs and measurements of your wounds at the start, after 7 days, and after 15 days (or when you leave the hospital, whichever comes first). You will return for a follow-up visit 3 months later to confirm the wound has fully healed.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
France